^
Association details:
Biomarker:No biomarker
Cancer:Prostate Cancer
Drug:Lutrate (leuprorelin depot) (GnRH agonist)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
LUTRATE DEPOT is a gonadotropin-releasing hormone (GnRH) agonist indicated for:….Treatment of advanced prostate cancer.